> top > docs > PubMed:7685420 > annotations

PubMed:7685420 JSONTXT

Annnotations TAB JSON ListView MergeView

DisGeNET

Id Subject Object Predicate Lexical cue
T0 502-511 gene:2064 denotes Her-2/neu
T1 545-566 disease:C1739363 denotes prostatic hypertrophy
T2 428-437 gene:2064 denotes Her-2/neu
T3 545-566 disease:C1739363 denotes prostatic hypertrophy
T4 664-673 gene:2064 denotes Her-2/neu
T5 586-610 disease:C0007112 denotes prostatic adenocarcinoma
R1 T0 T1 associated_with Her-2/neu,prostatic hypertrophy
R2 T2 T3 associated_with Her-2/neu,prostatic hypertrophy
R3 T4 T5 associated_with Her-2/neu,prostatic adenocarcinoma

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
7685420-2#28#37#gene2064 260-269 gene2064 denotes Her-2/neu
7685420-2#64#88#diseaseC0007112 296-320 diseaseC0007112 denotes prostatic adenocarcinoma
28#37#gene206464#88#diseaseC0007112 7685420-2#28#37#gene2064 7685420-2#64#88#diseaseC0007112 associated_with Her-2/neu,prostatic adenocarcinoma

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T680 119-128 gene:2064 denotes Her-2/neu
T681 158-171 disease:C0006142 denotes breast cancer
T682 176-190 disease:C0029925 denotes ovarian cancer
R1 T680 T681 associated_with Her-2/neu,breast cancer
R2 T680 T681 associated_with Her-2/neu,breast cancer
R3 T680 T682 associated_with Her-2/neu,ovarian cancer
R4 T680 T682 associated_with Her-2/neu,ovarian cancer

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-85 Sentence denotes Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
TextSentencer_T2 86-231 Sentence denotes Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis.
TextSentencer_T3 232-370 Sentence denotes We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on those of benign prostatic hypertrophy.
TextSentencer_T4 371-580 Sentence denotes Using a monoclonal antibody (TA1) directed against human Her-2/neu oncogene product and an immunohistochemical staining method, no Her-2/neu expression was noted with benign prostatic hypertrophy (15 samples).
TextSentencer_T5 581-674 Sentence denotes With prostatic adenocarcinoma samples, a subset (9 of 25) showed overexpression of Her-2/neu.
TextSentencer_T6 675-826 Sentence denotes Such overexpression is correlated with higher histological grade, higher stage of disease, and high S phase and aneuploidy on flow cytometric analysis.
TextSentencer_T7 827-919 Sentence denotes These findings suggest that Her-2/neu may be a prognostic marker in prostate cancer as well.
T1 0-85 Sentence denotes Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer.
T2 86-231 Sentence denotes Previous reports have shown that Her-2/neu oncogene expression in human breast cancer and ovarian cancer may be associated with poorer prognosis.
T3 232-370 Sentence denotes We report the expression of Her-2/neu on fresh samples of known prostatic adenocarcinoma but not on those of benign prostatic hypertrophy.
T4 371-580 Sentence denotes Using a monoclonal antibody (TA1) directed against human Her-2/neu oncogene product and an immunohistochemical staining method, no Her-2/neu expression was noted with benign prostatic hypertrophy (15 samples).
T5 581-674 Sentence denotes With prostatic adenocarcinoma samples, a subset (9 of 25) showed overexpression of Her-2/neu.
T6 675-826 Sentence denotes Such overexpression is correlated with higher histological grade, higher stage of disease, and high S phase and aneuploidy on flow cytometric analysis.
T7 827-919 Sentence denotes These findings suggest that Her-2/neu may be a prognostic marker in prostate cancer as well.

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 158-164 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 158-164 http://purl.obolibrary.org/obo/UBERON_0000310 denotes breast